Ovarian Cancer | Tumor

Getting to the Root of Better Gynecologic Cancer Treatment

August 22nd 2018

In recent decades, researchers have gained a much better understanding of how gynecologic cancers develop, especially for women who carry genetic mutations.

Personalizing Pain Management and Palliative Care in Ovarian Cancer

August 21st 2018

A common goal for palliative care is pain management, where opioids like morphine are often on the frontline. Then, practitioners may build on medications from there, adding agents such as gabapentin and tricyclic antidepressants. But if those don’t work, Christopher J. Pietras, M.D. said that ketamine may be an option.

Tumor Treating Fields Plus Paclitaxel Appears Safe, Effective in Recurrent Ovarian Cancer

August 13th 2018

The combination use of Tumor Treating Fields plus paclitaxel more than doubled progression-free survival, with no serious treatment-related side effects in women with recurrent, platinum-resistant ovarian cancer.

What to Expect When Going on a PARP Inhibitor for Ovarian Cancer

July 31st 2018

Chemotherapy and PARP inhibitors may share some side effects, but there are some major differences between the two when it comes to treating ovarian cancer.

Searching for Better Detection: The 'Holy Grail' of Ovarian Cancer

July 25th 2018

Researchers are on the hunt for a better biomarker in ovarian cancer that could detect the disease in earlier stages.

Advice for Newly-Diagnosed Ovarian Cancer: You Control Your Life

July 23rd 2018

We spoke to ovarian cancer survivors about their advice for women who are newly diagnosed.

Integrative Versus Alternative Cancer Therapy: Know the Difference and Which Can Help

July 20th 2018

An expert discusses ways to complement cancer treatment and potentially improve outcomes.

Treatment for Cancer's Twin Ailment: Financial Toxicity

July 19th 2018

The health care experts call it financial toxicity. I call it an agonizing, stress-inducing, horrifying choice between financial ruin and treatment of a life-threatening disease.

Cramps or Cancer: Elevated Menstrual Pain May be Associated with Ovarian Cancer Risk

July 17th 2018

Researchers reviewed the cases of more than 20,000 women – some who went on to develop ovarian cancer, and some who didn’t – and found that there was a small, but statistically significant increase in ovarian cancer incidence in women who reported having severe menstrual pain.

Ovarian Cancer Caregivers Have Unique Needs

July 15th 2018

Audra Moran, president and CEO of the Ovarian Cancer Research Fund Alliance, discusses the support available for caregivers of women with ovarian cancer.

Dream Team Evaluates Direct Testing of Tumors

July 15th 2018

Investigators are learning how to take a tumor biopsy from a patient, grow small tumors called organoids in the lab, and test cancer treatments on them to see which work best.

Recurrent Ovarian Cancer: Understand Your Treatment Options

July 15th 2018

Thanks to targeted drugs and evolving research, women who experience recurrences of ovarian cancer have more treatment options than they did in the past..

Regaining Intimacy After an Ovarian Cancer Diagnosis

July 15th 2018

Saketh Guntupalli, M.D., gynecologic oncologist at the University of Colorado Hospital, discusses ways that women can improve intimacy after an ovarian cancer diagnosis.

Newly Diagnosed With Ovarian Cancer? Take a Breath, Then Follow These Steps

July 15th 2018

The first thing a woman should do after receiving a diagnosis of ovarian cancer, according to Teresa P. Díaz-Montes, M.D., M.P.H., is nothing. At least not right away.

Exciting Advancements Underway in Ovarian Cancer

July 14th 2018

New treatments are continually being explored as researchers use genetic testing and genomic sequencing to better understand characteristics of ovarian cancer that can be targeted with drugs.

The Future of Ovarian Cancer: PARP Inhibition 'Leading the Way'

July 6th 2018

PARP inhibitors have made for new and exciting treatment options for ovarian cancer, but there is still much more work to be done, according to Dennis J. Slamon, M.D., Ph.D.

Examining Early-Life Adversity and the 'Stress Hormone' in Ovarian Cancer Survivors

July 3rd 2018

Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.

CURE's Top 5 Stories: June 2018

July 2nd 2018

Take a look at the top five CURE stories of June 2018 in this video.

Lynparza Prolongs Disease Progression in Advanced Ovarian Cancer

June 29th 2018

PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.

Exploring Another Biomarker in Ovarian Cancer

June 26th 2018

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.

Majority of Women With Ovarian Cancer Feel Uncomfortable Raising Psychological Concerns

June 25th 2018

A recent review of data found that 79 percent of patients with ovarian cancer felt uncomfortable raising psychological and emotional concerns during their consultations.

Zejula Shows Potential as More Than Just Maintenance Therapy

June 24th 2018

In the QUADRA study, treatment with Zejula (niraparib) demonstrated durable responses among women with relapsed or refractory ovarian cancer, regardless of BRCA mutation.

Testing Only the 'Tip of the Iceberg' for Common Hereditary Condition in MSI-H Tumors

June 14th 2018

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

FDA Approves Avastin Regimen for Ovarian Cancer Treatment

June 13th 2018

The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.

FDA Approves Paxman Cooling Cap for Solid Tumors

June 12th 2018

The FDA approved the Paxman Scalp Cooling System for patients with solid tumors who wish to prevent chemotherapy-related hair loss.

Genetic Testing: The 'Train That Keeps On Chugging'

June 5th 2018

Although genetic testing could be crucial in developing treatment plans and improving outcomes in women with ovarian and breast cancer, less than 20 percent of eligible patients actually get tested, according to Mike Janicek, M.D.

Expert Discusses the Evolving Field of Gynecologic Cancers

June 5th 2018

The field of ovarian cancer is changing rapidly, and moving toward an era of precision medicine.

A Brave, BeauTEALful Warrior

June 4th 2018

Sound Affects Seeks to Change Fight, Finances of War on Cancer

June 1st 2018

While many advocacy groups set out to raise money for cancer research, a first-of-its-kind charitable crowdfunding platform, called Sound Affects, has set out to change how the war on cancer is fought and financed, all with support from musical talents.

PARP Inhibitors Continue to Impress in the Ovarian Cancer Space

May 31st 2018

There are now three PARP inhibitors approved for the treatment of ovarian cancer, improving outcomes of many of the women who take them.